José Manuel Azaña
University of Alcalá
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by José Manuel Azaña.
International Journal of Dermatology | 1996
José Manuel Azaña; Ricardo F. de Misa; J. Casado; E. Muñoz; Antonio Ledo
1. Harrist TJ, Eine JD, Berman RS, et al. Neutropbilic eccrine bidradenitis: a distinctive type of neutrophilic dermatosis associated witb myelogenous leukemia and chemotherapy. Arch Dermatol 1982; 118:263-266. 2. Moisson YE, Aractingi S, Pinquier L, et al. Hidradenite eccrine neutropbilique. Ann Dermatoi Venereol 1992; 119:605-611. 3. Smith KJ, Skelton HG, James WD, et al. Neutrophilic eccrine bidradenitis in HIV-infected patients. J Am Acad Dermatol 1990; 23:945-947. 4. Pierson ]C, Helm TN, Taylor JS. Neutrophilic eccrine hidradenitis heralding tbe onset of acute myelogenous leukemia. Arch Dermatol 1993; 129:791-792.
Journal of Dermatology | 1995
Ricardo F. de Misa; José Manuel Azaña; A. Harto; Carmen Bellas; Antonio Ledo
Although diverse types of lymphomas have been examined for immunohistochemical detection of p53 protein, little information is available with regard to p53 protein expression in CTCL. We analyzed cutaneous biopsy specimens of 22 patients with the diagnoses of mycosis fungoides or Sézary syndrome with polyclonal rabbit anti‐p53 antiserum CM‐1. Staining of neoplastic cells was observed only in two patients with advanced disease. Overexpression of p53 protein does not seem to be a major feature of either mycosis fungoides or Sézary syndrome.
International Journal of Dermatology | 1994
Ricardo F. de Misa; José Manuel Azaña; Carmen Bellas; Bibiana Pérez; Antonio Rocamora; Antonio Ledo
A 73‐year‐old white woman was admitted to our hospital for evaluation of a chronic dermatitis. Personal history was remarkable only for arterial hypertension and noninsulin‐dependent6 diabetes mellitus. Clinical and histopathologic findings were consistent with a diagnosis of mycosis fundoides (mf and staging procedures including bolld cell counts, serum biochemistry, urinalysis, bone marrow biopsy, Sé zary cell counts in peripheral bolld, computerized tomography (ct scans, abdominal ultrasonography, chest roentgenograms, serum protein electrophoresis, and immunoelectrophoresis disclosed normal or negative results (T2 N0 M0 B0).
The Journal of Dermatologic Surgery and Oncology | 1994
Pablo Boixeda; Enrique Sánchez‐Miralles; José Manuel Azaña; José María Arrazola; Ramón Moreno; Antonio Ledo
Journal of The American Academy of Dermatology | 1993
José Manuel Azaña; R.F. de Misa; J.P. Boixeda; Antonio Ledo
Journal of The American Academy of Dermatology | 2005
Ricardo F. de Misa; A. Harto; José Manuel Azaña; Paulina Belmar; Esther Díez; Antonio Ledo
Archives of Dermatology | 1997
José Manuel Azaña; Ricardo F. de Misa; A. Harto; Antonio Ledo; Agustín España
Journal of The American Academy of Dermatology | 1994
R.F. de Misa; José Manuel Azaña; A. Harto; Pablo Boixeda; R. Moreno; Antonio Ledo
Journal of Dermatological Science | 1993
R.F. de Misa; José Manuel Azaña; A. Harto; Carmen Bellas
Journal of The American Academy of Dermatology | 1992
Ricardo F. de Misa; José Suárez; Susana Medina; José Manuel Azaña; Gloria Navas; Antonio Ledo